AAPL312.66+4.03 (+1.31%) ▲|ABBV254.76-6.31 (-2.42%) ▼|ABT95.63+0.23 (+0.24%) ▲|ACN136.96-0.39 (-0.28%) ▼|ADBE218.07-1.65 (-0.75%) ▼|AMAT592.79-10.25 (-1.70%) ▼|AMD552.05+34.23 (+6.61%) ▲|AMGN366.44-7.71 (-2.06%) ▼|AMT162.11-3.92 (-2.36%) ▼|AMZN244.16+1.49 (+0.61%) ▲|AVGO373.90+13.45 (+3.73%) ▲|AXP356.03+4.07 (+1.16%) ▲|BA234.54+8.05 (+3.55%) ▲|BAC59.90+1.17 (+1.99%) ▲|BKNG181.03-3.53 (-1.91%) ▼|BLK1,011.21+15.48 (+1.55%) ▲|BMY56.70-1.43 (-2.46%) ▼|BNY149.96+3.34 (+2.28%) ▲|BRK-B506.58-1.20 (-0.24%) ▼|C143.86+3.89 (+2.78%) ▲|CAT969.92+6.39 (+0.66%) ▲|CL93.39-1.74 (-1.83%) ▼|CMCSA23.38-0.41 (-1.72%) ▼|COF206.50+1.38 (+0.67%) ▲|COP103.58-1.15 (-1.10%) ▼|COST950.25-1.42 (-0.15%) ▼|CRM165.65-0.46 (-0.28%) ▼|CSCO113.98+1.29 (+1.14%) ▲|CVS102.08-2.64 (-2.52%) ▼|CVX168.10-1.10 (-0.65%) ▼|DE635.24+13.97 (+2.25%) ▲|DHR193.62-4.31 (-2.18%) ▼|DIS97.41-2.09 (-2.10%) ▼|DUK125.97-3.63 (-2.80%) ▼|EMR141.56+2.51 (+1.81%) ▲|FDX309.93-3.07 (-0.98%) ▼|GD376.88+3.34 (+0.89%) ▲|GE378.68+1.63 (+0.43%) ▲|GEV1,152.04+38.93 (+3.50%) ▲|GILD129.61-1.66 (-1.26%) ▼|GM77.85+1.85 (+2.43%) ▲|GOOG364.90+8.72 (+2.45%) ▲|GOOGL366.46+6.55 (+1.82%) ▲|GS1,055.29+34.29 (+3.36%) ▲|HD350.65-7.25 (-2.03%) ▼|HON231.18+1.32 (+0.57%) ▲|IBM299.52+10.00 (+3.45%) ▲|INTC122.20+1.85 (+1.54%) ▲|INTU272.14-3.21 (-1.17%) ▼|ISRG432.83+6.82 (+1.60%) ▲|JNJ259.33-3.71 (-1.41%) ▼|JPM337.72+4.75 (+1.43%) ▲|KO82.96-1.18 (-1.40%) ▼|LIN540.52-6.12 (-1.12%) ▼|LLY1,200.06-13.85 (-1.14%) ▼|LMT538.00-7.91 (-1.45%) ▼|LOW223.78-3.72 (-1.64%) ▼|LRCX350.20-1.21 (-0.34%) ▼|MA533.10-6.29 (-1.17%) ▼|MCD279.50-1.13 (-0.40%) ▼|MDLZ59.17-1.74 (-2.86%) ▼|MDT83.06-0.13 (-0.16%) ▼|META600.29+17.39 (+2.98%) ▲|MMM159.15-1.29 (-0.80%) ▼|MO71.88-0.83 (-1.14%) ▼|MRK126.78-2.78 (-2.15%) ▼|MS222.10+8.17 (+3.82%) ▲|MSFT386.74-3.75 (-0.96%) ▼|MU984.75+9.19 (+0.94%) ▲|NEE87.44-0.90 (-1.02%) ▼|NFLX76.02-1.63 (-2.10%) ▼|NKE43.34-0.75 (-1.70%) ▼|NOW107.93+1.61 (+1.51%) ▲|NVDA195.55+0.72 (+0.37%) ▲|ORCL143.76+3.49 (+2.49%) ▲|PEP143.29-0.93 (-0.64%) ▼|PFE23.72-0.60 (-2.47%) ▼|PG149.31-2.10 (-1.39%) ▼|PLTR132.54+3.24 (+2.51%) ▲|PM184.76+2.49 (+1.37%) ▲|QCOM186.48+10.23 (+5.80%) ▲|RTX201.37+2.12 (+1.06%) ▲|SBUX102.11-2.16 (-2.07%) ▼|SCHW100.62+3.62 (+3.73%) ▲|SO95.99-1.99 (-2.03%) ▼|SPG225.00-1.06 (-0.47%) ▼|T20.58+0.00 (+0.00%) ▲|TMO517.60-5.84 (-1.12%) ▼|TMUS181.79+4.27 (+2.41%) ▲|TSLA419.77+26.32 (+6.69%) ▲|TXN303.50+10.42 (+3.56%) ▲|UBER72.42-2.01 (-2.70%) ▼|UNH417.99-7.37 (-1.73%) ▼|UNP282.59+0.34 (+0.12%) ▲|UPS110.02-0.64 (-0.58%) ▼|USB62.83+1.10 (+1.78%) ▲|V357.25-4.88 (-1.35%) ▼|VZ42.07-0.49 (-1.15%) ▼|WFC87.45+1.94 (+2.27%) ▲|WMT110.65-1.19 (-1.06%) ▼|XOM136.44-0.65 (-0.47%) ▼|AAPL312.66+4.03 (+1.31%) ▲|ABBV254.76-6.31 (-2.42%) ▼|ABT95.63+0.23 (+0.24%) ▲|ACN136.96-0.39 (-0.28%) ▼|ADBE218.07-1.65 (-0.75%) ▼|AMAT592.79-10.25 (-1.70%) ▼|AMD552.05+34.23 (+6.61%) ▲|AMGN366.44-7.71 (-2.06%) ▼|AMT162.11-3.92 (-2.36%) ▼|AMZN244.16+1.49 (+0.61%) ▲|AVGO373.90+13.45 (+3.73%) ▲|AXP356.03+4.07 (+1.16%) ▲|BA234.54+8.05 (+3.55%) ▲|BAC59.90+1.17 (+1.99%) ▲|BKNG181.03-3.53 (-1.91%) ▼|BLK1,011.21+15.48 (+1.55%) ▲|BMY56.70-1.43 (-2.46%) ▼|BNY149.96+3.34 (+2.28%) ▲|BRK-B506.58-1.20 (-0.24%) ▼|C143.86+3.89 (+2.78%) ▲|CAT969.92+6.39 (+0.66%) ▲|CL93.39-1.74 (-1.83%) ▼|CMCSA23.38-0.41 (-1.72%) ▼|COF206.50+1.38 (+0.67%) ▲|COP103.58-1.15 (-1.10%) ▼|COST950.25-1.42 (-0.15%) ▼|CRM165.65-0.46 (-0.28%) ▼|CSCO113.98+1.29 (+1.14%) ▲|CVS102.08-2.64 (-2.52%) ▼|CVX168.10-1.10 (-0.65%) ▼|DE635.24+13.97 (+2.25%) ▲|DHR193.62-4.31 (-2.18%) ▼|DIS97.41-2.09 (-2.10%) ▼|DUK125.97-3.63 (-2.80%) ▼|EMR141.56+2.51 (+1.81%) ▲|FDX309.93-3.07 (-0.98%) ▼|GD376.88+3.34 (+0.89%) ▲|GE378.68+1.63 (+0.43%) ▲|GEV1,152.04+38.93 (+3.50%) ▲|GILD129.61-1.66 (-1.26%) ▼|GM77.85+1.85 (+2.43%) ▲|GOOG364.90+8.72 (+2.45%) ▲|GOOGL366.46+6.55 (+1.82%) ▲|GS1,055.29+34.29 (+3.36%) ▲|HD350.65-7.25 (-2.03%) ▼|HON231.18+1.32 (+0.57%) ▲|IBM299.52+10.00 (+3.45%) ▲|INTC122.20+1.85 (+1.54%) ▲|INTU272.14-3.21 (-1.17%) ▼|ISRG432.83+6.82 (+1.60%) ▲|JNJ259.33-3.71 (-1.41%) ▼|JPM337.72+4.75 (+1.43%) ▲|KO82.96-1.18 (-1.40%) ▼|LIN540.52-6.12 (-1.12%) ▼|LLY1,200.06-13.85 (-1.14%) ▼|LMT538.00-7.91 (-1.45%) ▼|LOW223.78-3.72 (-1.64%) ▼|LRCX350.20-1.21 (-0.34%) ▼|MA533.10-6.29 (-1.17%) ▼|MCD279.50-1.13 (-0.40%) ▼|MDLZ59.17-1.74 (-2.86%) ▼|MDT83.06-0.13 (-0.16%) ▼|META600.29+17.39 (+2.98%) ▲|MMM159.15-1.29 (-0.80%) ▼|MO71.88-0.83 (-1.14%) ▼|MRK126.78-2.78 (-2.15%) ▼|MS222.10+8.17 (+3.82%) ▲|MSFT386.74-3.75 (-0.96%) ▼|MU984.75+9.19 (+0.94%) ▲|NEE87.44-0.90 (-1.02%) ▼|NFLX76.02-1.63 (-2.10%) ▼|NKE43.34-0.75 (-1.70%) ▼|NOW107.93+1.61 (+1.51%) ▲|NVDA195.55+0.72 (+0.37%) ▲|ORCL143.76+3.49 (+2.49%) ▲|PEP143.29-0.93 (-0.64%) ▼|PFE23.72-0.60 (-2.47%) ▼|PG149.31-2.10 (-1.39%) ▼|PLTR132.54+3.24 (+2.51%) ▲|PM184.76+2.49 (+1.37%) ▲|QCOM186.48+10.23 (+5.80%) ▲|RTX201.37+2.12 (+1.06%) ▲|SBUX102.11-2.16 (-2.07%) ▼|SCHW100.62+3.62 (+3.73%) ▲|SO95.99-1.99 (-2.03%) ▼|SPG225.00-1.06 (-0.47%) ▼|T20.58+0.00 (+0.00%) ▲|TMO517.60-5.84 (-1.12%) ▼|TMUS181.79+4.27 (+2.41%) ▲|TSLA419.77+26.32 (+6.69%) ▲|TXN303.50+10.42 (+3.56%) ▲|UBER72.42-2.01 (-2.70%) ▼|UNH417.99-7.37 (-1.73%) ▼|UNP282.59+0.34 (+0.12%) ▲|UPS110.02-0.64 (-0.58%) ▼|USB62.83+1.10 (+1.78%) ▲|V357.25-4.88 (-1.35%) ▼|VZ42.07-0.49 (-1.15%) ▼|WFC87.45+1.94 (+2.27%) ▲|WMT110.65-1.19 (-1.06%) ▼|XOM136.44-0.65 (-0.47%) ▼|
19.4 C
New York
Monday, July 6, 2026

Tag: plans

newssourceFORcompanyinformationcontent1releasesmarket

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous Nephropathy

CAMBRIDGE, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – announced the initiation of dosing in the global clinical study, PROMINENT. The Phase 3 study will evaluate the efficacy and safety of the investigational drug felzartamab compared to tacrolimus in adults diagnosed with primary membranous nephropathy (PMN). PROMINENT is designed to enroll approximately 180 adults with PMN and expected to readout in 2029. PMN is a severe antibody-mediated disease of the kidney that is a leading cause of nephrotic syndrome and carries a significant risk of kidney failure.

GR Silver Mining Strengthens Management Structure and Provides Corporate Update

VANCOUVER, BC, June 30, 2025 /CNW/ - GR Silver Mining Ltd. ("GR Silver Mining" or the "Company") (TSXV: GRSL) (OTCQB: GRSLF) (FRANKFURT: GPE) – is...

Shanghai Electric Ranks 47th on World Brand Lab’s “China’s 500 Most Valuable Brands” List with Brand Value of US$31.8 Billion

The continuous improvement of Shanghai Electric's brand value is due to a resilient long-term development structure with a strong focus on ESG management. SHANGHAI, June 30,...

Cielo Announces AGM Results and Extension of Unit Offering

Cielo Announces AGM Results and Extension of Unit Offering

Regenx Amends Debenture Terms and Announces Non-Brokered Financing for Gross Proceeds of $555,664

Regenx extends debenture maturity to July 2026, lowers conversion price to $0.05, and secures $555K non-brokered financing to support operations.

Verny Capital Signs Agreement to Sell RG Gold

ASTANA, Kazakhstan, June 30, 2025 /PRNewswire/ -- Verny Capital Group has signed an agreement to sell the gold mining company RG Gold, which it has...

Verny Capital Signs Agreement to Sell RG Gold

ASTANA, Kazakhstan, June 30, 2025 /PRNewswire/ -- Verny Capital Group has signed an agreement to sell the gold mining company RG Gold, which it has...

As New Energy Tax Policy Takes Shape, T1 Energy Confident It is Well Positioned

T1 discusses emerging budget bill tax policy, including 45X Production Tax Credit, stackability, transferability and the potential for an excise tax.

Arizona Metals Announces 2025 Mineral Resource Estimate for Kay Mine Project

/NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR...

Qifu Technology Announces Results of Annual General Meeting

SHANGHAI, China, June 30, 2025 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading AI-empowered Credit-Tech platform in China, today announced that the following proposed resolutions submitted for shareholder approval have been duly adopted at its annual general meeting of shareholders held today:

HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line...

— Approval based on Phase III SACHI Trial results which showed a 66% reduced risk of progression or death as compared to platinum-based chemotherapy —

Jo Malone London New Campaign featuring Adwoa Aboah, JOMO

LONDON, June 30, 2025 /PRNewswire/ -- Goodbye FOMO, hello JOMO. Cancel plans and stay home luxuriating in Jo Malone London bath & body treats,...

Hanon Systems Releases 2024 Sustainability Report

Key highlights include SBTi validation of carbon emission reduction targets and recognition in S&P Global's 2025 Sustainability YearbookEighth consecutive sustainability report, fourth report published...

Leading the Charge: Eddid Financial’s Two-Year Journey into Digital Assets and the Emerging RWA Frontier

HONG KONG, June 30, 2025 /PRNewswire/ -- In a move that has sparked widespread industry discussion, a major mainland Chinese brokerage recently received approval...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPlans

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers